Lip, GYH, Nikorowitsch, J, Sehner, S, Becher, N, Bertaglia, E, Blomstrom-Lundqvist, C, Brandes, A, Beuger, V, Calvert, M, Camm, AJ, Chlouverakis, G, Dan, G-A, Dichtl, W, Diener, HC, Fierenz, A, Goette, A, de Groot, JR
, Hermans, A, Lubinski, A, Marijon, E, Merkely, B, Mont, L, Ozga, A-K, Rajappan, K, Sarkozy, A, Scherr, D, Schnabel, RB
, Schotten, U, Simantirakis, E, Toennis, T, Vardas, P, Wichterle, D, Zapf, A, Kirchhof, P & NOAH-AFNET 6 investigators 2024, '
Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial',
European Heart Journal, vol. 45, no. 19, ehae225, pp. 1733-1737.
https://doi.org/10.1093/eurheartj/ehae225